{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:27:41Z","timestamp":1759692461577,"version":"3.40.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1989,1,1]],"date-time":"1989-01-01T00:00:00Z","timestamp":599616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1989,1]]},"DOI":"10.1007\/bf03349913","type":"journal-article","created":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T03:24:59Z","timestamp":1397013899000},"page":"31-35","source":"Crossref","is-referenced-by-count":18,"title":["Effects of the opiate agonist loperamide on pituitary-adrenal function in patients with suspected hypercortisolism"],"prefix":"10.1007","volume":"12","author":[{"given":"Bruno","family":"Ambrosi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bochicchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ferrario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Faglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,9]]},"reference":[{"key":"BF03349913_CR1","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(78)92100-1","volume":"2","author":"WA Stubbs","year":"1978","unstructured":"Stubbs W.A, Delitala G., Jones A., Jeffcoate W.J., Edwards C.R.W., Ratter S.J., Besser G.M., Bloom F.R., Alberti K.G.M.M. Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet 2: 1225, 1978.","journal-title":"Lancet"},{"key":"BF03349913_CR2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000179275","volume":"13","author":"E Pozo Del","year":"1980","unstructured":"Del Pozo E., Von Graffenried B., Brownell J., Derrer F., Marbach P. Endocrine effect of a methionine-enkephalin derivative (FK 33\u2013824) in man. Horm. Res. 13: 90, 1980.","journal-title":"Horm. Res."},{"key":"BF03349913_CR3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2265.1981.tb00636.x","volume":"14","author":"RC Gaillard","year":"1981","unstructured":"Gaillard R.C., Grossman A., Smith R., Rees L.H., Besser G.M. The effects of a met-enkephalin analogue on ACTH, \u03b2-LPH, \u03b2-endorphin and met-enkephalin in patients with adrenocortical disease. Clin. Endocrinol. (Oxf.) 14: 471, 1981.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03349913_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jcem-55-1-1","volume":"55","author":"B Allolio","year":"1982","unstructured":"Allolio B., Winkelmann W., Hipp F.X., Karlen D., Mies R. Effects of a met-enkephalin on adrenocorticotropin (ACTH), growth hormone and prolactin in patients with ACTH hypersecretion. J. Clin. Endocrinol. Metab. 55: 1, 1982.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03349913_CR5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2265.1986.tb03276.x","volume":"24","author":"B Ambrosi","year":"1986","unstructured":"Ambrosi B., Bochicchio D., Faglia G. Loperamide, an opiate analogue, inhibits plasma ACTH levels in patients with Addison\u2019s disease. Clin. Endocrinol. (Oxf.) 24: 483, 1986.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"Suppl.256","key":"BF03349913_CR6","first-page":"201","volume":"256","author":"B Ambrosi","year":"1983","unstructured":"Ambrosi B., Bochicchio D., Riva E., Faglia G. Influence of loperamide on ACTH, GH and PRL levels in patients with ACTH hypersecretion. Acta Endocrinol. (Kbh.) 256(Suppl. 256): Abs. 201, 1983.","journal-title":"Acta Endocrinol. (Kbh.)"},{"key":"BF03349913_CR7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2265.1985.tb03240.x","volume":"22","author":"U Deuss","year":"1985","unstructured":"Deuss U., Allolio B., Kaulen D., Fischer H., Winkelmann W. Effects of high-dose and low-dose naloxone on plasma ACTH in patients with ACTH hypersecretion. Clin. Endocrinol. (Oxf.) 22: 273, 1985.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03349913_CR8","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1210\/jcem-63-6-1427","volume":"63","author":"B Allolio","year":"1986","unstructured":"Allolio B., Deuss U., Kaulen D., Leonhardt U., Kallabis D., Hamel E., Winkelmann W. FK 33\u2013824, a met-enkephalin analog, blocks Corticotropin-Releasing Hormone-induced Adrenocorticotropin secretion in normal subjects but not in patients with Cushing\u2019s disease. J. Clin. Endocrinol. Metab. 63: 1427, 1986.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03349913_CR9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1530\/acta.0.1100170","volume":"110","author":"B Baranowska","year":"1985","unstructured":"Baranowska B., Dorobek W., Misiorowski W., Jeske W., Abdel-Fattah M.H. The effect of naloxone on ACTH and \u03b2-endorphin in patients with Cushing\u2019s disease. Acta Endocrinol. (Kbh.) 110: 170, 1985.","journal-title":"Acta Endocrinol. (Kbh.)"},{"key":"BF03349913_CR10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0022-3565(25)30664-6","volume":"199","author":"RC Mackerer","year":"1976","unstructured":"Mackerer R.C., Clay G.A., Dajani E.Z. Loperamide binding to opiate receptor sites of brain and myenteric plexus. J. Pharmacol. Exp. Therap. 199: 131, 1976.","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"BF03349913_CR11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1159\/000125070","volume":"48","author":"D Bochicchio","year":"1988","unstructured":"Bochicchio D., Ambrosi B., Faglia G. Loperamide, an opiate analog, differently modifies the ACTH responses to CRH and Lysine-vasopressin in patients with Addison\u2019s disease. Neuroendocrinology 48: 611, 1988.","journal-title":"Neuroendocrinology"},{"key":"BF03349913_CR12","volume-title":"Beyond Normality: The Predictive value and Efficiency of Medical Diagnoses","author":"RS Galen","year":"1975","unstructured":"Galen R.S., Gambino S.R. Beyond Normality: The Predictive value and Efficiency of Medical Diagnoses. John Wiley & Sons, New York, 1975."},{"key":"BF03349913_CR13","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1210\/jcem-54-4-780","volume":"54","author":"G Tolis","year":"1982","unstructured":"Tolis G., Jukier L., Wiesen M., Krieger D.T. Effect of naloxone on pituitary hypersecretory syndromes. J. Clin. Endocrinol. Metab. 54: 780, 1982.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03349913_CR14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jcem-47-3-667","volume":"47","author":"JF Caro","year":"1978","unstructured":"Caro J.F., Meikle A.W., Check J.H. \u201cNormal suppression\u201d to dexamethasone in Cushing\u2019s disease: an expression of decreased metabolic clearance for dexamethasone. J. Clin. Endocrinol. Metab. 47: 667, 1978.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03349913_CR15","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0026-0495(79)90097-0","volume":"21","author":"L Crapo","year":"1979","unstructured":"Crapo L. Cushing\u2019s syndrome: a review of diagnostic tests. Metabolism 21: 955, 1979","journal-title":"Metabolism"},{"key":"BF03349913_CR16","first-page":"349","volume-title":"Advances in pituitary adenoma research","author":"B Allolio","year":"1988","unstructured":"Allolio B., Winkelmann W., Kaulen D., Reincke M., Jaursch-Hancke C., Schrell U., Fahlbusch R. A reversible defect in the opioidergic control of ACTH release in Cushing\u2019s disease. In: Landolt A.M., Heitz P.U., Zapf J., Girard J., Del Pozo E. (Eds.), Advances in pituitary adenoma research. Pergamon Press, Oxford, 1988, p. 349."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03349913.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03349913\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03349913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T09:24:59Z","timestamp":1746177899000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03349913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1989,1]]}},"alternative-id":["BF03349913"],"URL":"https:\/\/doi.org\/10.1007\/bf03349913","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"type":"print","value":"0391-4097"},{"type":"electronic","value":"1720-8386"}],"subject":[],"published":{"date-parts":[[1989,1]]}}}